Schmidt A, Schwagmeier R, Broja E, Nolte H
Institut für Anaesthesiologie, Klinikum Minden.
Reg Anaesth. 1990 Sep;13(7):159-62.
There is some controversy about the relationship of volume, concentration and total dose of bupivacaine in the sensory spread of spinal anesthesia. In this study the effects of volume and dose were investigated. MATERIAL AND METHODS. In this study 120 patients undergoing lower extremity, inguinal or transurethral surgery were randomly divided into six groups. Bupivacaine 15 mg with the addition of epinephrine 1:200,000 was administered in 2 ml (0.75%), 3 ml (0.5%), 6 ml (0.25%) and 9 ml (0.166%) solutions. In addition 3 ml isobaric bupivacaine in doses of 7.5 mg (0.25%), 15 mg (0.5%) and 22.5 mg (0.75%). The spinal puncture was performed via the midline approach at the L3-4 interspace, with the patient in the sitting position. The injection speed was 0.5 ml per second. Immediately after the injection the patients were placed in the supine position. The spread of sensory blockade was assessed by means of the pin-prick method in the midline. Motor blockade was assessed on the Bromage scale 0-3. RESULTS. There were no statistically significant differences in motor blockade or cardiovascular changes. The maximum cephalad spread of analgesia (30 min) between the 15 mg groups with different volumes and concentration was: group I (9 ml): T7.7, group II (6 ml): T7.8, group III (3 ml): T8.5 and group IV (2 ml): T10.1. The differences between group IV 2 ml and the groups receiving 3, 6 and 9 ml were statistically significant (P less than 0.05). There were no statistically significant differences in maximum cephalad spread between the 7.5 mg (3 ml), 15 mg (3 ml) and the 22.5 mg (3 ml) groups. The regression after 180 min was significantly shorter in the 7.5 mg group than in the 15 mg and 22.5 mg groups (P less than 0.05). DISCUSSION. Earlier published results indicate that the dose of isobaric bupivacaine is more important in spinal anesthesia than the concentration or the volume of the solution. The comparison between 3 ml:6 ml and 3 ml:9 ml bupivacaine showed no statistically significant differences in cephalad spread. A volume-dependent increase in segmental spread was between the 2 ml (0.75%) and 3 ml (0.5%) bupivacaine. The same statistically significant differences were between the 2 ml and 6 ml groups and the 2 ml and 9 ml groups. No statistically significant difference in cephalad spread resulted from increasing the dose of bupivacaine from 7.5 mg to 22.5 mg. Earlier studies on the effects of changes in volume, concentration and dose of bupivacaine showed similar "jumps of blockade" between 2 ml and 3 ml injected volume. Assembling the results the relation between volume and total dose does not suggest a no linear dependence. The anatomic configuration of the spinal cord at the conus medullaris may affect the distribution of the solution.
关于布比卡因的容量、浓度和总剂量在脊髓麻醉感觉平面扩散中的关系存在一些争议。在本研究中,对容量和剂量的影响进行了调查。材料与方法。在本研究中,120例接受下肢、腹股沟或经尿道手术的患者被随机分为六组。将15mg布比卡因加入1:200,000肾上腺素,分别配制成2ml(0.75%)、3ml(0.5%)、6ml(0.25%)和9ml(0.166%)的溶液进行给药。此外,还有3ml等比重布比卡因,剂量分别为7.5mg(0.25%)、15mg(0.5%)和22.5mg(0.75%)。通过中线法在L3 - 4椎间隙进行脊髓穿刺,患者取坐位。注射速度为每秒0.5ml。注射后立即将患者置于仰卧位。通过中线针刺法评估感觉阻滞的扩散。采用Bromage 0 - 3级评估运动阻滞。结果。运动阻滞或心血管变化方面无统计学显著差异。不同容量和浓度的15mg组之间,镇痛的最大头端扩散(30分钟)情况为:第一组(9ml):T7.7,第二组(6ml):T7.8,第三组(3ml):T8.5,第四组(2ml):T10.1。第四组2ml与接受3ml、6ml和9ml的组之间差异有统计学意义(P小于0.05)。7.5mg(3ml)、15mg(3ml)和22.5mg(3ml)组之间最大头端扩散无统计学显著差异。7.5mg组180分钟后的消退明显短于15mg和22.5mg组(P小于0.05)。讨论。早期发表的结果表明,等比重布比卡因的剂量在脊髓麻醉中比溶液的浓度或容量更重要。3ml:6ml和3ml:9ml布比卡因之间在头端扩散方面无统计学显著差异。2ml(0.75%)和3ml(0.5%)布比卡因之间节段扩散存在容量依赖性增加。2ml与6ml组以及2ml与9ml组之间也有相同的统计学显著差异。将布比卡因剂量从7.5mg增加到22.5mg,头端扩散无统计学显著差异。早期关于布比卡因容量、浓度和剂量变化影响的研究显示,在2ml和3ml注射容量之间存在类似的“阻滞跳跃”。综合结果来看,容量与总剂量之间的关系并非呈线性依赖。脊髓圆锥处脊髓的解剖结构可能会影响溶液的分布。